JP Morgan Chase’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93 Hold
15
﹤0.01% 7317
2025
Q4
$177 Hold
15
﹤0.01% 7177
2025
Q3
$120 Buy
15
+1
+7% +$7 ﹤0.01% 7157
2025
Q2
$109 Sell
14
-16
-53% -$117 ﹤0.01% 6829
2025
Q1
$209 Buy
30
+16
+114% +$173 ﹤0.01% 6794
2024
Q4
$155 Hold
14
﹤0.01% 6949
2024
Q3
$191 Hold
14
﹤0.01% 6909
2024
Q2
$217 Hold
14
﹤0.01% 6780
2024
Q1
$369 Sell
14
-55
-80% -$1.32K ﹤0.01% 6753
2023
Q4
$1.39K Sell
69
-400
-85% -$5.52K ﹤0.01% 6783
2023
Q3
$6.17K Buy
469
+406
+644% +$6.67K ﹤0.01% 6338
2023
Q2
$1.2K Sell
63
-29,387
-100% -$581K ﹤0.01% 6435
2023
Q1
$564K Hold
29,450
﹤0.01% 4421
2022
Q4
$813K Sell
29,450
-111
-0.4% -$2.8K ﹤0.01% 4198
2022
Q3
$739K Sell
29,561
-8,069
-21% -$318K ﹤0.01% 4228
2022
Q2
$1.78M Sell
37,630
-1,247
-3% -$58.2K ﹤0.01% 3645
2022
Q1
$2.41M Buy
38,877
+9,204
+31% +$759K ﹤0.01% 3612
2021
Q4
$3.77M Sell
29,673
-9,557
-24% -$1.56M ﹤0.01% 3296
2021
Q3
$7.82M Buy
39,230
+712
+2% +$170K ﹤0.01% 2627
2021
Q2
$10.2M Buy
38,518
+21,762
+130% +$6.73M ﹤0.01% 2422
2021
Q1
$5.86M Buy
16,756
+7,139
+74% +$3.05M ﹤0.01% 2833
2020
Q4
$4.92M Buy
9,617
+9,364
+3,701% +$3.75M ﹤0.01% 2826
2020
Q3
$66K Buy
253
+24
+10% +$8.26K ﹤0.01% 4861
2020
Q2
$125K Buy
+229
New +$103K ﹤0.01% 4473

Other funds holding PASG

JP Morgan Chase's PASG Position: Q1 2026 in Review

JP Morgan Chase held its Passage Bio (PASG) position steady in Q1 2026 at 15 shares worth $93. The position accounts for ﹤0.01% of the portfolio, ranked #7317.

JP Morgan Chase first reported a position in PASG in Q2 2020 and has held it in 24 quarters since. The position peaked at $10.2M in Q2 2021. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • JP Morgan Chase held 15 shares of Passage Bio worth $93 as of Q1 2026.
  • JP Morgan Chase left its Passage Bio share count unchanged in Q1 2026.
  • Passage Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7317 holding.
  • JP Morgan Chase first reported a position in Passage Bio in Q2 2020 and has held it in 24 quarters since.
  • JP Morgan Chase's Passage Bio position peaked at $10.2M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.